HTDS reports Gross Revenues of $5.39M for Fiscal Year ended December 31, 2009

NewsGuard 100/100 Score

Profits Over $600,000 USD

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) and its China based subsidiary Mellow Hope update shareholders on the company's 2009 revenues and profits.

With Fiscal Year ending on December 31st, HTDS announces that the company generated $5.39 million USD in Gross Revenues, with profits reaching $621,000 USD in 2009. The company gladly shares these sound numbers with the shareholders, and expects to increase its revenues in 2010. As the company does not subscribe to Pink Sheets filing service, the detailed financials are posted on HTDS IR company web site section "CLIENT SUPPORT" TAB, www.minamargroup.net, or this direct link http://minamarmarketinggroup.helpserve.com/, and HTDS web site.

A source close to HTDS, said, "We had a great 2009, and we don't expect any less from 2010. In 2009 we pushed our company deeper into the international vaccine trade, completed a number of solid deals and hoisted HTDS' name on the international markets. As 2010 progresses, we continue working on a number of promising market opportunities like those in India and Chile. HTDS internal projects are also well underway: We just completed the merger with Collagenna Skin Care which will market under the Melem Secrets brand. This will jumpstart our expansion into cosmetics market; and continue our assessment of the regenerative medicine and the stem cell bank projects in Europe. We have a lot on our plate today, but these substantial changes will create stronger and well-diversified HTDS for the future. Moving forward, revenues from Collagenna will also be included in our balance sheets."

The company reminds our shareholders and followers that the company does not subscribe to the PinkSheets.com Filing Service. Its IR company web site section "CLIENT SUPPORT" TAB, www.minamargroup.net, or this direct link http://minamarmarketinggroup.helpserve.com/ should be reviewed by its followers for further updates on this and other business matters. Non-newsworthy events are not press released however posted on this separate support site to keep our followers advised of day-to-day events, and the company corporate web site. For any matters relating to retail investor queries or to send us the company directly a message please click on the "INVESTOR SUPPORT" TAB or this direct link www.minamargroup.net/helpdesk.

Don't be a victim. Report a stock basher. The company is mindful that short sellers, the company competitors and stock bashers stalk small cap Pink Sheets listed companies with hidden agendas, where amongst other things they continuously spread false rumours, dark propaganda and innuendos in order to manipulate the trading patterns and thwart company plans for their own "quick profits" and self serving needs. The company and its supporters are monitoring these activities and those are promptly being reported on the www.stockbasher.com web site.

Back to top
Source:

Hard to Treat Diseases

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.